Is SCPH or DIVO a better dividend investment in 2026?

SCPH currently yields 35.27% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: SCPH offers higher current income.

What is the dividend yield difference between SCPH and DIVO?

SCPH has a forward dividend yield of 35.27% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 28.65 percentage points.

Home › Compare › SCPH vs DIVO

SCPH vs DIVO: Dividend Comparison 2026

SCPH yields 35.27% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SCPH wins by $147.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SCPH

● Live price

35.27%

Share price

$5.67

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$178.6K

Annual income

$27,157.20

Full SCPH calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — SCPH vs DIVO

📍 SCPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SCPH	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SCPH + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SCPH pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCPH

Annual income on $10K today (after 15% tax)

$2,998.24/yr

After 10yr DRIP, annual income (after tax)

$23,083.62/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, SCPH beats the other by $22,226.42/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCPH + DIVO for your $10,000?

SCPH: 50%DIVO: 50%

100% DIVO50/50100% SCPH

Portfolio after 10yr

$104.8K

Annual income

$14,082.84/yr

Blended yield

13.44%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SCPH right now

SCPH

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$8.12

+43.2% upside vs current

Range: $5.35 — $13.00

Altman Z

-7.3

Piotroski

2/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCPH buys

DIVO buys

No recent congressional trades found for SCPH or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSCPHDIVO

Forward yield	35.27% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$178.6K ✓	$31.0K
Annual income after 10y	$27,157.20 ✓	$1,008.47
Total dividends collected	$129.2K ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SCPH vs DIVO ($10,000, DRIP)

Year	SCPH Portfolio	SCPH Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$14,227	$3,527.34	$11,362	$661.96	+$2.9K → SCPH
2	$19,913	$4,690.15	$12,860	$702.91	+$7.1K → SCPH
3	$27,442	$6,135.14	$14,504	$743.56	+$12.9K → SCPH
4	$37,265	$7,901.67	$16,303	$783.73	+$21.0K → SCPH
5	$49,902	$10,028.00	$18,268	$823.31	+$31.6K → SCPH
6	$65,945	$12,549.99	$20,408	$862.17	+$45.5K → SCPH
7	$86,061	$15,499.75	$22,737	$900.20	+$63.3K → SCPH
8	$110,989	$18,904.51	$25,266	$937.31	+$85.7K → SCPH
9	$141,544	$22,785.49	$28,008	$973.42	+$113.5K → SCPH
10	$178,609	$27,157.20	$30,977	$1,008.47	+$147.6K → SCPH

SCPH vs DIVO: Complete Analysis 2026

SCPH — Stock

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Full SCPH Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this SCPH vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCPH vs SCHD SCPH vs JEPI SCPH vs O SCPH vs KO SCPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.